Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSB | P07858 | 5/20 | 0.52 |
| ▸ | CTSL | P07711 | 4/20 | 0.52 |
| ▸ | CTSK | P43235 | 4/20 | 0.52 |
| ▸ | CTSS | P25774 | 2/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CTRB1 | P17538 | 2/20 | 0.46 |
| ▸ | PSMB1 | P20618 | 1/20 | 0.46 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.46 |
| ▸ | PSMB2 | P49721 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7271139 | 0.96 | CTSL (0.56) | CTSBCTSLCTSKCTSSALDH1A1 | |
| SCHEMBL7271134 | 0.96 | CTSL (0.56) | CTSBCTSLCTSKCTSSALDH1A1 | |
| SCHEMBL24447908 | 0.95 | CTSL (0.50) | CTSBCTSLCTSKCTSSALDH1A1 | |
| SCHEMBL8138447 | 0.95 | CTSL (0.50) | CTSBCTSLCTSKCTSSALDH1A1 | |
| SCHEMBL7280270 | 0.85 | CTSB (0.55) | CTSBCTSLCTSKCTSSALDH1A1 | |
| SCHEMBL15649121 | 0.82 | CTSK (0.62) | CTSBCTSLCTSKCTSS | |
| SCHEMBL22122405 | 0.82 | CTSK (0.62) | CTSBCTSLCTSKCTSS | |
| SCHEMBL12247730 | 0.82 | SYK (0.53) | CTSBCTSLCTSKALDH1A1CYP1A2 | |
| SCHEMBL12249929 | 0.81 | YAP1 (0.56) | — | |
| SCHEMBL5275940 | 0.80 | CTSK (0.59) | CTSBCTSLCTSKCTSSCTRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2137139-B1 | PROCESS OF DEACETALISATION OF ALPHA AMINOACETALS | CLARIANT SPECIALTY FINE CHEM (FR) | 2014-09-10 | — | — | EP | disclosed |
| CN-101679223-B | Deacetalization of alpha aminoacetals | CLARIANT SPECIALTY FINE CHEM | 2014-04-16 | — | — | CN | disclosed |
| US-8609882-B2 | Process for deacetalisation of α aminoacetals | CLARIANT SPECIALITY FINE CHEMICALS (FRANCE) (FR) | 2013-12-17 | — | — | US | disclosed |
| US-20100137633-A1 | Process For Deacetalisation Of Alpha Aminoacetals | CLARIANT SPECIALTY FINE CHEMICALS (FRANCE) (FR) | 2010-06-03 | — | — | US | disclosed |
| CN-101679223-A | Deacetalization of alpha aminoacetals | CLARIANT SPECIALTY FINE CHEM | 2010-03-24 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100137633-A1 | Process For Deacetalisation Of Alpha Aminoacetals | ALDH7A1, AADAT, AASDHPPT | CTSB 1587/4885CTSL 1941/4885CTSK 1982/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.